Rapafusyn Pharmaceuticals
Baltimore
About Rapafusyn Pharmaceuticals
Rapafusyn Pharmaceuticals licenses technology related to a novel class of natural product-like macrocycle. The company develops novel pharmaceuticals to treat patients having diseases and fulfill other unmet medical needs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $44.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2025)
- Website: rapafusyn.com
- Phone: +1 (410) 995-8234
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/rapafusyn-pharmaceuticals-98609 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.